Clinical Trial Update: Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CC-486 in previously treated locally advanced or metastatic nasopharyngeal carcinoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Neoplasms

Drugs mentioned

• CC-486 (azacitidine)

Snippet

Sponsor: Celgene | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2018-06-01